“The ministry will regulate CBN as a designated drug under the pharmaceutical and medical devices law through a revision of a relevant ordinance.
Original story
Continue reading at Japan Times Latest
www.japantimes.co.jp
Summary generated from the RSS feed of Japan Times Latest. All article rights belong to the original publisher. Click through to read the full piece on www.japantimes.co.jp.
